Haleon buys back £230m in shares after Pfizer offloads £2.43bn stake.
Pharma giant Pfizer has offloaded a £2.43bn stake in Haleon, which in turn said it would buy back £230m of the shares.
Pfizer Inc.
01 October 2024 08:15:09
Source: Sharecast
Haleon, maker of Sensodyne toothpaste, said it had bought the shares at 308p each. The off-market purchase includes 30.1 million shares worth around £114.6m which will be cancelled and represent the remainder of the £500mallocated to share buybacks in 2024.
The rest of the shares will be held as treasury shares for the purposes of satisfying Haleon's obligations under its existing employee share plans in 2025. Haleon said Pfizer’s stake was expected to fall to 15% from 22.6%.
Haleon was created as a joint venture with GSK before being listed in July 2022 as a consumer healthcare company.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.